Takeda Pharmaceutical Co Financial Overview
Takeda Pharmaceutical Co's market cap is currently ¥7.30T. The company's EPS TTM is ¥-7.83; its P/E ratio is 213.29; and it has a dividend yield of 4.30%. Takeda Pharmaceutical Co is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is ¥53.20. See an overview of income statement, balance sheet, and cash flow financials.
